Genetic Technologies Insider Trades

GENE

Track insider trading activity from Genetic Technologies executives and directors. See which insiders are buying and selling GENE stock.

Trades Last 12 Months

All Insider Trades for Genetic Technologies

Sort by: Latest Trade Biggest Holding
Insider
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Patou Gary Chief Medical Officer
Holding Value $0 0 shares
Last Trade
Feb 10, 2007 Sale
$3.55B 928,463 shares
$3,825.00
$0.76
Holding Value $457k 597,367 shares
Last Trade
Jul 01, 2004 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
No data
No data
$0.76
Stone David K Director
Holding Value $97.7k 127,665 shares
Last Trade
May 05, 2004 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
No data
No data
$0.76
Riedel Norbert G Director
Holding Value $105k 137,896 shares
Last Trade
May 05, 2004 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
No data
No data
$0.76
Evnin Luke Director
Holding Value $29.1k 38,013 shares
Last Trade
Apr 13, 2004 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
No data
No data
$0.76
Rutter William J Director
Holding Value $36.9k 48,271 shares
Last Trade
Apr 13, 2004 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
No data
No data
$0.76
Holding Value $13k 17,054 shares
Last Trade
Apr 13, 2004 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
No data
No data
$0.76
Holding Value $697k 911,366 shares
Last Trade
Jun 26, 2003 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
No data
No data
$0.76

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up